Efficacy of Brock String Therapy Post Concussion

November 2, 2023 updated by: Alicia Trbovich, University of Pittsburgh

Brock String Therapy for Receded Near Point of Convergence Post Concussion

The purpose of the proposed study is to evaluate the efficacy of Brock String therapy prescribed in the acute stage of concussion recovery can improve clinical outcomes among patients with receded near point of convergence (NPC).

Aim 1: Determine if participants receiving the Brock String have more significant improvements in NPC measurements at follow up 7-10 days post injury.

Aim 2: Determine if participants receiving the Brock String 1) improve on computerized neurocognitive test scores from initial visit (<48 hours post injury) to follow up visit (7-10 days post injury) compared to control participants, and 2) have reduced recovery time (i.e., days from injury until return to play) compared to control participants.

Study Overview

Detailed Description

Receded near point of convergence (NPC) is a common oculomotor deficit associated with numerous vision diagnoses, including convergence and accommodative insufficiencies, following sport-related concussion (SRC). Researchers have found associations with worse neurocognitive test scores, higher post-concussion symptom burden, and longer recovery among patients with receded NPC relative to concussion patients with normal NPC. Although oculomotor dysfunction may resolve spontaneously or improves with vision therapy exercises in the post-acute phase of recovery, it is unclear if early intervention can improve recovery outcomes. The Brock String is a cost effective and practical vision therapy exercise for congenital convergence insufficiency (CI), and initial research supports effectiveness with SRC patients who have receded NPC in the subacute phase of recovery (e.g., weeks to months post injury). Early vision therapy intervention may be efficacious in improving recovery times and reduce healthcare costs by eliminating later therapies for chronic deficits.

Study Type

Interventional

Enrollment (Estimated)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Cynthia Holland, MPH
  • Phone Number: 412-904-1298
  • Email: clh197@pitt.edu

Study Locations

    • Pennsylvania
      • Pittsburgh, Pennsylvania, United States, 15203
        • Recruiting
        • University of Pittsburgh Medical Center, Rooney Sports Complex
        • Contact:
          • Alicia Trbovich, PhD
        • Principal Investigator:
          • Alicia M Trbovich, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

12 years to 20 years (Child, Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Athletes who sustained a concussion during organized sport within past 48 hours
  • ages 12-20
  • at least one NPC measurement >10 centimeters at initial clinic evaluation.

Exclusion Criteria:

  • lack of access to a smart phone to receive text message prompts
  • vestibular disorder
  • seizure disorder
  • history of traumatic brain injury with imaging findings or brain surgery
  • history of 3+ concussions\
  • concussion within the past 6 months
  • history of developmental or intellectual disability
  • history of substance abuse
  • Patients will also be excluded from recruitment if the treating clinician feels the potential participant would be unable to tolerate Brock String therapy due to severe symptoms

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Brock String
Participants will receive instruction on Brock String therapy after first clinic visit (<48 hours post) injury, and will complete home therapy exercise twice daily
Oculomotor exercise to improve binocular vision function
Active Comparator: Standard of Care
Participants will receive standard of care (i.e., no Brock String therapy within the first week post injury) but will be informed they will receive any therapy deemed necessary at follow up visit 7-10 days post injury, consistent with standard of care
patient engages in normal behavior to manage vision issues, such as breaks with reading and screen use

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Near point of convergence measurement
Time Frame: from visit 1 (<48 hours post injury) to visit 2 (7-10 days post injury)
change in convergence measurement from nose in centimeters
from visit 1 (<48 hours post injury) to visit 2 (7-10 days post injury)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Immediate Post Concussion Assessment and Cognitive Testing (ImPACT
Time Frame: from visit 1 (<48 hours post injury) to visit 2 (7-10 days post injury)
change in test scores based on normative data percentile (range <1-100); for all composite scores, including verbal memory, visual memory, visual motor speed scores, reaction time; better score indicating better performance
from visit 1 (<48 hours post injury) to visit 2 (7-10 days post injury)
concussion recovery duration
Time Frame: from day of injury until final clinic visit, determined by concussion symptoms resolving and all aspects of testing within normal limits; expected range 7-10 days to up to 6 months post injury
recovery time (i.e., days from injury until return to play)
from day of injury until final clinic visit, determined by concussion symptoms resolving and all aspects of testing within normal limits; expected range 7-10 days to up to 6 months post injury

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Alicia Trbovich, PhD, University of Pittsburgh
  • Principal Investigator: Anthony P Kontos, PhD, University of Pittsburgh

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 9, 2020

Primary Completion (Estimated)

April 1, 2024

Study Completion (Estimated)

May 1, 2024

Study Registration Dates

First Submitted

August 27, 2019

First Submitted That Met QC Criteria

August 29, 2019

First Posted (Actual)

September 3, 2019

Study Record Updates

Last Update Posted (Actual)

November 3, 2023

Last Update Submitted That Met QC Criteria

November 2, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Concussion, Brain

Clinical Trials on Brock String Therapy

3
Subscribe